CHRISTINE ABLETT: Open Payments
NPI 1134452832 · NORTHFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,300 in 66 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $1,300
Food & beverage: $1,112Education: $188
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $180 |
| AstraZeneca Pharmaceuticals LP | 10 | $178 |
| Daiichi Sankyo Inc. | 8 | $145 |
| Astellas Pharma US Inc | 2 | $107 |
| Pharmacosmos Therapeutics Inc. | 4 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Celgene Corporation | 3 | $54 |
| TerSera Therapeutics LLC | 3 | $54 |
| Gilead Sciences, Inc. | 3 | $45 |
| Novocure Inc. | 2 | $41 |
Products named: Enhertu, JAKAFI, MONOFERRIC, Nubeqa, REBLOZYL, Zoladex, CALQUENCE, Trodelvy.
Industry payments across NJ — which companies pay providers there.
